Clinical trial
Use of Implanting the Biotronik Passeo-18 Lux Drug Coated Balloon to Treat Failing Hemodialysis Arteriovenous Fistulas and Grafts
NCT04381754 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Implanting the Biotronik Passeo-18 Lux Drug Coated Balloon to Treat Failing Hemodialysis Arteriovenous Fistulas and Grafts
- Lead sponsor
- Singapore General Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 30, 2020
- Completion date
- June 30, 2022
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arterio-venous fistula, arteriovenous graft stenosis, dialysis access malfunction, hemodialysis access failure